Thrombocytosis work-up
thrombocytosis w/u · Haematology / Oncology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
A high platelet count is far more often reactive (infection, inflammation, iron deficiency, malignancy) than clonal. The work-up separates reactive thrombocytosis from a myeloproliferative neoplasm such as essential thrombocythaemia.
Red flags
- Thrombosis or TIA/stroke
- Extreme thrombocytosis (>1000-1500 x10^9/L) with bleeding (acquired von Willebrand)
- Splanchnic vein thrombosis
- Weight loss / anaemia suggesting occult malignancy
- Erythromelalgia with ischaemia
Assessment
Differential diagnosis
- Reactive (infection, inflammation, surgery, trauma)
- Iron deficiency
- Essential thrombocythaemia
- Other myeloproliferative neoplasms (PV, CML, MF)
- Post-splenectomy / hyposplenism
- Occult malignancy
Investigations
- FBC trend and blood film
- CRP/ESR and ferritin (reactive causes)
- JAK2 V617F; CALR and MPL if JAK2 negative
- BCR::ABL1 to exclude CML
- Bone marrow if clonal disorder suspected
- Imaging/assessment for occult malignancy if clinically indicated
Management
- Confirm the platelet count is genuinely and persistently raised
- Review for obvious reactive causes: infection, inflammation, bleeding, surgery, iron deficiency
- Check ferritin and inflammatory markers
- If no reactive cause or features suggest clonality, test JAK2 V617F
- If JAK2 negative, test CALR and MPL mutations and exclude CML with BCR::ABL1
- Examine the film and consider marrow for essential thrombocythaemia diagnosis
- Risk-stratify essential thrombocythaemia for thrombosis (age, prior thrombosis, JAK2, cardiovascular risk)
- Treat reactive thrombocytosis by addressing the cause - cytoreduction is not needed
- For essential thrombocythaemia give aspirin and cytoreduction in high-risk patients
- Monitor for thrombotic/haemorrhagic complications and disease evolution
Drugs & doses
Aspirin 75-100 mg PO once daily (essential thrombocythaemia, reduce thrombosis)
Hydroxycarbamide 15-20 mg/kg/day PO (high-risk ET cytoreduction)
Anagrelide or interferon as alternative cytoreductive agents
Treat iron deficiency / reactive cause as appropriate
Disposition
Primary care for clearly reactive causes; haematology for suspected clonal disease and ongoing ET management.
Complications & pitfalls
- Arterial and venous thrombosis
- Paradoxical bleeding (acquired von Willebrand syndrome at very high counts)
- Transformation of ET to myelofibrosis or leukaemia
- Microvascular symptoms
- Pregnancy complications in ET
Exam pearls
- Most thrombocytosis is reactive and needs no cytoreduction
- Iron deficiency is a common and reversible cause
- Very high platelet counts can paradoxically cause bleeding via acquired von Willebrand syndrome - caution with aspirin
- JAK2, CALR and MPL cover most essential thrombocythaemia
- Always exclude CML with BCR::ABL1
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.